Zepp Health FY25 net loss narrows 47.1% to US$ 40.07 million

Zepp Health Corp

Zepp Health Corp

ZEPP

0.00
  • Zepp Health fiscal 2025 net loss narrowed to US$40.07 million from US$75.81 million.
  • Revenue climbed 41.8% to US$258.9 million on growth across sports, balance, youth product lines.
  • Operating loss shrank to US$29.23 million from US$47.25 million.
  • Amazfit-branded products rose to 100% of revenue from 94%.
  • Zepp expects current cash and anticipated operating cash flow to cover general corporate needs for at least next 12 months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zepp Health Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-048127), on April 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.